Live from the NIH registry
Studies recruiting near Oceanside right now
Top 25 of 717 recruiting studies, sorted by proximity — each links to its official registry page
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications
Phase 3
Interventional 115 participants sought
University of California San Diego Moores Cancer Center (Adults only) — La Jolla, California (26.2 mi)
· Sponsor: Pierre Fabre Medicament
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Brain Tumor, Recurrent, Brain Tumor
N/A
Observational 600 participants sought
UCSD Moores Cancer Center — La Jolla, California (26.2 mi)
· Sponsor: GT Medical Technologies, Inc.
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
Parkinson Disease
N/A
Observational 4,500 participants sought
University of California San Diego — La Jolla, California (26.2 mi)
· Sponsor: Michael J. Fox Foundation for Parkinson's Research
OssiMend BA in Posterolateral Instrumented Lumbar Fusion
Spinal Disease, Degenerative Disc Disease
N/A
Observational 120 participants sought
San Diego Neurosurgery — Encinitas, California (13.0 mi)
· Sponsor: Collagen Matrix
Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder
Neuromyelitis Optica Spectrum Disorder
Phase 2
Interventional 15 participants sought
UCSD Altman Clinical and Translational Research Institute Building — La Jolla, California (26.2 mi)
· Sponsor: Amgen
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
Colitis, Ulcerative
N/A
Observational 300 participants sought
Scripps Clinic Torrey Pines — La Jolla, California (26.2 mi)
· Sponsor: Pfizer
Phage Therapy for Recurrent UTIs in Kidney Transplant Recipients
Urinary Tract Infection, Recurrent
Phase 1, Phase 2
Interventional 32 participants sought
University of California, San Diego — La Jolla, California (26.2 mi)
· Sponsor: University of California, San Diego
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
NSCLC (Advanced Non-small Cell Lung Cancer), HNSCC
Phase 1
Interventional 170 participants sought
ALX Center 9 — La Jolla, California (26.2 mi)
· Sponsor: ALX Oncology Inc.
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Breast Neoplasms, Neoplasm Metastasis
Phase 3
Interventional 800 participants sought
Profound Research LLC — Oceanside, California (4.6 mi)
· Sponsor: Eli Lilly and Company
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Headlands Research California, LLC — Escondido, California (14.8 mi)
· Sponsor: Medtronic MiniMed, Inc.
ATLAS-1: Advanced Trial for Longitudinal Assessment in Salma 1
Depressed Mood
N/A
Observational 5,000 participants sought
Salma Health — La Jolla, California (26.2 mi)
· Sponsor: Salma Health, Inc.
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Overweight , Obesity, Adults
Phase 2
Interventional 220 participants sought
Profound Research — Oceanside, California (4.6 mi)
· Sponsor: Alveus Therapeutics, Inc.
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
Chronic Lymphocytic Leukemia (CLL)
Phase 2
Interventional 75 participants sought
Moores Cancer Center at UC San Diego /ID# 230157 — La Jolla, California (26.2 mi)
· Sponsor: AbbVie
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
Recurrent Glioblastoma, IDH-Wildtype, Recurrent MGMT-Methylated Glioblastoma
Phase 1, Phase 2
Interventional 97 participants sought
UC San Diego Moores Cancer Center — La Jolla, California (26.2 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Alzheimers Disease, Dementia
Phase 2, Phase 3
Interventional 280 participants sought
University of California San Diego Medical Center — La Jolla, California (26.2 mi)
· Sponsor: Washington University School of Medicine
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
NSCLC (Advanced Non-small Cell Lung Cancer)
Phase 1, Phase 2
Interventional 675 participants sought
UC San Diego Moores Cancer Center — La Jolla, California (26.2 mi)
· Sponsor: BlossomHill Therapeutics
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Breast Cancer
Phase 3
Interventional 450 participants sought
Kaiser Permanente - San Marcos — San Marcos, California (10.0 mi)
· Sponsor: Hoffmann-La Roche
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — La Jolla, California (26.2 mi)
· Sponsor: Daiichi Sankyo
Radicle GI Health DBG: A Study Assessing the Impact of Health and Wellness Products on GI Health and Related Health Outcomes
Belly Pain, GI Health
N/A
Interventional 825 participants sought
Radicle Science Inc. — Del Mar, California (18.5 mi)
· Sponsor: Radicle Science
Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With Tardive Dyskinesia
Tardive Dyskinesia
Phase 2
Interventional 100 participants sought
Neurocrine Clinical Site — Temecula, California (20.7 mi)
· Sponsor: Neurocrine Biosciences
Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial
Plasma Cell Leukemia
Phase 2
Interventional 74 participants sought
UC San Diego Moores Cancer Center — La Jolla, California (26.2 mi)
· Sponsor: National Cancer Institute (NCI)
Allograft Dysfunction in Heart Transplant
Heart Transplant Failure and Rejection
Phase 4
Interventional 376 participants sought
UC San Diego — La Jolla, California (26.2 mi)
· Sponsor: Paul Kim
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Metabolic Dysfunction-Associated SteatoHepatitis (MASH)
Phase 2
Interventional 120 participants sought
Cadena Care Inst. — Poway, California (24.0 mi)
· Sponsor: Regeneron Pharmaceuticals
Bone Mineral Density Agreement Study Between EOSedge™ Versus Traditional DXA
Healthy, Indicated for EOSedge Imaging
N/A
Interventional 214 participants sought
ATEC Carlsbad — Carlsbad, California (5.2 mi)
· Sponsor: Alphatec Spine, Inc.
FORWARD CAD IDE Study
Coronary Arterial Disease (CAD)
N/A
Interventional 408 participants sought
Scripps Health — La Jolla, California (26.2 mi)
· Sponsor: Shockwave Medical, Inc.